Colon Cancer Clinical Trial
A Prospective Single-Center Evaluation of SureForm™ Staplers in Robotic-assisted Colorectal Procedures
The primary objective of this study is to evaluate the performance of SureFormâ„¢ Staplers (60 and 45) for transection and/or creation of anastomosis during robotic-assisted colorectal procedures.
This is a prospective, single-center observational study to evaluate the performance of SureForm™ Staplers during robotic-assisted resections of either ascending or transverse or descending or sigmoid colon or rectum. Subjects with either a suspected or confirmed benign or malignant disease of the colon and rectum who are scheduled to undergo a robotic-assisted resection of the colon or rectum will be asked to provide informed consent for their participation in the study.
The study will be conducted at one institution with two surgeons performing the colorectal procedures. The surgeons will be using either the da Vinci Xi or X Surgical System which ever they use as per their standard of care for the colorectal procedure. Stapling will be performed with SureForm™ Staplers and any of the reloads as per the surgeon's standard of care for the transection and/or creation of anastomosis during robotic-assisted colorectal procedures.
The subject must be 18 years of age or older at the time of consent
Subject undergoing robotic-assisted colorectal procedure for benign or malignant colon or rectal disease, where SureForm™Staplers are utilized for transection and/or creation of anastomosis
Subject has had prior neoadjuvant (chemotherapy and/or radiation) therapy
Subject with active bacterial or fungal infection
Subject is contraindicated for general anesthesia or surgery
Subject is undergoing an emergency procedure
Subject has other major concomitant procedures (e.g. hepatectomies, incisional ventral hernia repair, nephrectomies, hysterectomy) planned along with colorectal procedure.
Subject has metastatic disease and/or subject has life expectancy of less than 1 year
Subject is under an immunomodulatory or immunosuppressive regimen (e.g. transplant patient, steroid requirement) within 30 days prior to the planned surgical procedure
Subject has history of coagulation or hematologic disorder
Pregnant or suspect pregnancy
The subject is unable to comply with the follow-up visit schedule
Subject has perforated, obstructing or locally invasive neoplasm (T4b)
Subject with inflammatory bowel disease
Subject is mentally handicapped or has a psychological disorder or severe systemic illness that would preclude compliance with study requirements or ability to provide informed consent
Subject belonging to other vulnerable population, e.g, prisoner or ward of the state
Intra-Operative Exclusion Criteria:
Subjects who require extensive dissection to release adhesions or with advanced cancer which may result in anastomotic leak and/or bleeding unrelated to the stapler.
Inadequate visualization making an endoscopic approach not feasible
Anatomy determined intra-operatively to be unsuitable for minimally invasive surgery
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Tulsa Oklahoma, 74137, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.